Please assess the completion status of the following clinical trial:

Trial Title: Microbiome and Metagenome in Percutaneous Osseointegrated Prostheses (MMPOP)

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Is a US military Veteran with transfemoral limb loss, that occurred at least 6 months prior to consent, and that the amputation is not a result of dysvascular disease.~2. Is at least 18 years of age or older.~3. Has previously used or is currently using a socket suspension technology prosthesis~4. Has, in the opinion of the investigator, normal cognitive function and no physical limitations, addictive diseases, or underlying medical conditions including tobacco use (continued testing for tobacco use will be performed at screening) that may prevent the subject from being an appropriate study candidate.~5. Is willing, able, and committed to participation in baseline and follow-up evaluations for the entire duration of the study.~6. Can provide written informed consent to participate.~Exclusion Criteria:~1. Is currently on active or reserve military duty~2. Has experienced systemic bacterial infection or localized infection at the stump site within the previous 6 months~3. Has had more than 1 limb amputated~4. Has a body mass index (BMI) 30~5. Has insulin dependent diabetes mellitus (IDDM) or has adult onset DM with a glycated hemoglobin (HbA1c) \> 53 mmol/mol (7.0%) at screening~6. Has residual femur bone length of less than 25% of the length of the contralateral femur.~7. Has clinically diagnosed vascular compromise proximal to the surgical site~8. Is pregnant at the time of surgery or plans to become pregnant within the first year of follow-up~9. Has evidence of recent tobacco use (urine cotinine test \> 300 ng/mL \[1703 nmol/L\]) and is not committed to a smoking-cessation program~10. Has renal insufficiency (defined as serum creatinine of 1.8 mg/dL) or is currently receiving renal dialysis~11. Is currently involved in or plans to be involved in high levels of physical activity (competitive sports, heavy physical labor, etc) during the first 12 months of the rehabilitation stage~12. Has muscular, neurologic or vascular deficiencies that may compromise the bone or soft tissue healing of the affected extremity~13. Has anemia characterized by a hemoglobin of 11 g/dL at the time of surgery~14. Is currently on oral anticoagulation (excluding low-dose aspirin for cardiac prophylaxis)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- POP 10 patient cohort (Type: None): This is an observational study

Based on this trial design, predict the completion outcome and termination type (if applicable).